Products

What will AGI do for Aclatonium napadisilate?

This classification denotes a cholinergic agonist with the molecular formula 2C10H20NO4.C10H6O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YX23434YHQ, chemically known as 2-(2-(acetyloxy)-1-oxopropoxy)-n,n,n-trimethylethanaminium, 1,5-naphthalenedisulfonate (2:1) but generally known as aclatonium napadisilate, which bears US NIH Compound Identifier 41315. European Medicines Agency schedules Aclatonium napadisilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05244MIG. The term ACLATONIUM NAPADISILATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). Most nations schedule aclatonium napadisilate under HS 29239000 and SITC 51481. As of Q4 2014, ACLATONIUM NAPADISILATE remains the US FDA Preferred Term for this commodity. Aclatonium napadisilate bears US NLM identifiers UMLS ID C0076758 and NCI Concept Code C91037. SMILES: CC(C(=O)OCC[N+](C)(C)C)OC(=O)C.CC(C(=O)OCC[N+](C)(C)C)OC(=O)C.C1=CC2=C(C=CC=C2S(=O)(=O)[O-])C(=C1)S(=O)(=O)[O-].

How AGI delivers it

Four ways AGI delivers for Aclatonium napadisilate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aclatonium napadisilate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aclatonium napadisilate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aclatonium napadisilate connects

measured by

  • Assay Puritymodel
  • Related Substancesmodel
  • Residual Solventsmodel